我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

国产富马比索洛尔耐受量及其对心功能的影响(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2003年第2期
页码:
142-143,146
栏目:
临床研究
出版日期:
2003-03-01

文章信息/Info

Title:
Tolerance dose of homemade bisoprolol fumarate tablet sandits effects on left ventricular functions
作者:
石玉1席晓萍2杨继庆3张三奇1周晓东4
第四军医大学:1.西京医院药剂科,3.物理教研室,4.超声诊断科,陕西 西安 710032; 2.武警北京总队医院特检科,北京 100027)
Author(s):
SHI Yu1XI Xiao-ping2YANG Ji-qing3ZHANG San-qi1ZHOU Xiao-dong4
1.Department of Pharmacy,Xi jing Hospital,Fourth Military Medical University,Xi'an,Shaanxi710032,China
关键词:
富马比索洛尔心力衰竭充血性射血分数
Keywords:
bisoprolol fumarateheart failurecongestiveejection fraction
分类号:
R541.4
DOI:
-
文献标识码:
A
摘要:
目的:观察国人对国产富马比索洛尔的最大耐受剂量,及其对心功能的影响。方法:心力衰竭患者56例,在口 服地高辛、ACEI制剂、血管扩张剂(非钙离子拮抗剂)和利尿剂等基本抗心力衰竭药物的基础上,加服富马比索洛 尔。观察患者对此药的耐受性,同时在试验初始时和服药7月后测定患者左室射血分数(EF)等指标。结果:心力衰 竭患者服用富马比索洛尔的最大耐受剂量各不同,主要分布在5mg;随访7月后,复查心脏B超与试验初比较,EF 值(30.5±2.3)% vs(42.3±3.2)%,有极显著的改善(P<0.01)。结论:在心力衰竭治疗用药的基础上,加用富马 比索洛尔治疗(按照个体化用药原则),国人对此药的耐受程度主要分布在5mg,治疗7月后的心力衰竭患者心功 能显著改善。
Abstract:
AIM:To study the effects of homemade bisoprolol fumarate (BF) tablets on left ventricular functions of patients with chronic heart failure and its maximum to lerance dose.METHODS:There were 56 patients with chronic heart failure.The maximum tolerance doses of BF taken by each patient per day and each time were recorded to analyseits guidelines,and the left ventricular ejection fractions (EF) were also recorded to evaluate the effect so fBF.RESULTS:There were differences in the maximum to lerance doses of BF foreach patient,but the dose was distributed mostly at 5mg.After 7 months follow up,values of EF were far higher than those before the test (30.5±2.3)% vs(42.3±3.2)%,(P<0.01). CONCLUSION: With 7 months treatment of bisoprolol fumarate added to other basic drugs (used differently according to different patients),the heart function of the patients with heart failure improve significantly. The tolerance dose for national people is mostly distributed at 5mg

参考文献/References

[1]Eichhon EF,Bristow MR.Practical guidelines of initation of beta-adrenergic blockade in patients with chronic heart failure [J]. Am J Cardiol,1997,79:794-797.

[2]方圻.β受体阻滞剂用于充血性心力衰竭的治疗[J].中华心血管病杂志,1999,27:470-472.

[3] Paker M.Effects of beta-adrenergic blockade on survival of patients with chronic heart failure [J]. Am J Cardiol,1997,80(S):46-54.

[4] CIBIS-Ⅱ investigatorsand committees. The insufficiency bisoprolol studyⅡ (CIBIS-Ⅱ):A randomized trial [J].Lancet, 1999, 353:9-13.

[5]Copie X,Pousset F,Lechat P,et al. Effects of beta-blockade with chronic heart rate variability in advanced heart failure:analysis of scatterplots of RR intervals at selected heart rates[J].Am Heart J,1996,132:368-375.

[6] Nolan J,Batin P, And rews R,et al.Prospective study of heart rate varuabuluty and mortality in chronic heart failure:results of the United Kingdom Heart Failure Evaluation and Assessment Trail (UKheart) [J]. Circulation, 1998,98:1510-1516.

[7]刘新国,杨新国,李志立,等.心率变异性评价心力衰竭及其等级的临床应用[J].心脏杂志,2000,12(2):102-104.

[8]戴闺柱.我国在心力衰竭研究的主要成就[J].中华心血管病杂志,1999,27:272-273.

备注/Memo

备注/Memo:
收稿日期:2002-9-9.
更新日期/Last Update: 2003-03-01